2016•Neuromuscular DisordersRequires access

Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials

Joana Domingos, Michelle Eagle, Amélie Moraux, Jordan W. Butler, V. Decostre, Deborah A. Ridout, A. Mayhew, Victoria L. Selby, Michela Guglieri, Menno van der Holst, Merel Jansen, Jan J.G.M. Verschuuren, Imelda J. M. de Groot, Erik Harmen Niks, Laurent Servais, Jean‐Yves Hogrel, Volker W. Straub, Thomas Voit, V. Ricotti, Francesco Muntoni

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Duchenne muscular dystrophy, Medicine, Ambulatory, Natural history, Vital capacity, Physical therapy, Natural history study, Muscular dystrophy